These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 33245136)

  • 61. Sociodemographic Characteristics and Comorbidities of Patients With Long COVID and Persistent Olfactory Dysfunction.
    Mendes Paranhos AC; Nazareth Dias ÁR; Machado da Silva LC; Vieira Hennemann Koury G; de Jesus Sousa E; Cerasi AJ; Souza GS; Simões Quaresma JA; Magno Falcão LF
    JAMA Netw Open; 2022 Sep; 5(9):e2230637. PubMed ID: 36074464
    [TBL] [Abstract][Full Text] [Related]  

  • 62. COVID-19 and Parkinson's disease: Defects in neurogenesis as the potential cause of olfactory system impairments and anosmia.
    Rethinavel HS; Ravichandran S; Radhakrishnan RK; Kandasamy M
    J Chem Neuroanat; 2021 Sep; 115():101965. PubMed ID: 33989761
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prevalence of Loss of Smell and/or Taste and other Otorhinolaryngology Symptoms in COVID-19 Patients.
    Shrestha I; Mishra A; Mishra A; Bista M; Acharya J
    Kathmandu Univ Med J (KUMJ); 2021; 19(74):173-179. PubMed ID: 34819431
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The Prevalence of Olfactory Dysfunction in the General Population: A Systematic Review and Meta-analysis.
    Desiato VM; Levy DA; Byun YJ; Nguyen SA; Soler ZM; Schlosser RJ
    Am J Rhinol Allergy; 2021 Mar; 35(2):195-205. PubMed ID: 32746612
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Smell dysfunction in COVID-19 patients: More than a yes-no question.
    Lima MA; Silva MTT; Oliveira RV; Soares CN; Takano CL; Azevedo AE; Moraes RL; Rezende RB; Chagas IT; Espíndola O; Leite AC; Araujo A
    J Neurol Sci; 2020 Nov; 418():117107. PubMed ID: 32866813
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Anosmia: an evolution of our understanding of its importance in COVID-19 and what questions remain to be answered.
    Saussez S; Lechien JR; Hopkins C
    Eur Arch Otorhinolaryngol; 2021 Jul; 278(7):2187-2191. PubMed ID: 32909060
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Self-reported olfactory and gustatory dysfunctions in COVID-19 patients: a 1-year follow-up study in Foggia district, Italy.
    Fortunato F; Martinelli D; Iannelli G; Milazzo M; Farina U; Di Matteo G; De Nittis R; Ascatigno L; Cassano M; Lopalco PL; Prato R
    BMC Infect Dis; 2022 Jan; 22(1):77. PubMed ID: 35065619
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Recent Smell Loss Is the Best Predictor of COVID-19 Among Individuals With Recent Respiratory Symptoms.
    Gerkin RC; Ohla K; Veldhuizen MG; Joseph PV; Kelly CE; Bakke AJ; Steele KE; Farruggia MC; Pellegrino R; Pepino MY; Bouysset C; Soler GM; Pereda-Loth V; Dibattista M; Cooper KW; Croijmans I; Di Pizio A; Ozdener MH; Fjaeldstad AW; Lin C; Sandell MA; Singh PB; Brindha VE; Olsson SB; Saraiva LR; Ahuja G; Alwashahi MK; Bhutani S; D'Errico A; Fornazieri MA; Golebiowski J; Dar Hwang L; Öztürk L; Roura E; Spinelli S; Whitcroft KL; Faraji F; Fischmeister FPS; Heinbockel T; Hsieh JW; Huart C; Konstantinidis I; Menini A; Morini G; Olofsson JK; Philpott CM; Pierron D; Shields VDC; Voznessenskaya VV; Albayay J; Altundag A; Bensafi M; Bock MA; Calcinoni O; Fredborg W; Laudamiel C; Lim J; Lundström JN; Macchi A; Meyer P; Moein ST; Santamaría E; Sengupta D; Rohlfs Dominguez P; Yanik H; Hummel T; Hayes JE; Reed DR; Niv MY; Munger SD; Parma V;
    Chem Senses; 2021 Jan; 46():. PubMed ID: 33367502
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID-19 patients.
    Moein ST; Hashemian SM; Tabarsi P; Doty RL
    Int Forum Allergy Rhinol; 2020 Oct; 10(10):1127-1135. PubMed ID: 32761796
    [TBL] [Abstract][Full Text] [Related]  

  • 70. "Anosmia" the mysterious collateral damage of COVID-19.
    Ahmed AK; Sayad R; Mahmoud IA; El-Monem AMA; Badry SH; Ibrahim IH; Hafez MH; El-Mokhtar MA; Sayed IM
    J Neurovirol; 2022 Apr; 28(2):189-200. PubMed ID: 35249186
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Predictive factors of smell recovery in a clinical series of 288 coronavirus disease 2019 patients with olfactory dysfunction.
    Saussez S; Sharma S; Thiriard A; Olislagers V; Vu Duc I; Le Bon SD; Khalife M; Hans S; De Riu G; Hopkins C; Lechien JR; Vaira LA; Marchant A
    Eur J Neurol; 2021 Nov; 28(11):3702-3711. PubMed ID: 34157187
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Olfactory dysfunction in SARS-CoV-2 infection: Focus on odorant specificity and chronic persistence.
    Rebholz H; Pfaffeneder-Mantai F; Knoll W; Hassel AW; Frank W; Kleber C
    Am J Otolaryngol; 2021; 42(5):103014. PubMed ID: 33873048
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A review of smell and taste dysfunction in COVID-19 patients.
    Wong DKC; Gendeh HS; Thong HK; Lum SG; Gendeh BS; Saim A; Salina H
    Med J Malaysia; 2020 Sep; 75(5):574-581. PubMed ID: 32918429
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms.
    Yan CH; Faraji F; Prajapati DP; Boone CE; DeConde AS
    Int Forum Allergy Rhinol; 2020 Jul; 10(7):806-813. PubMed ID: 32279441
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prevalence of subjective impairments of the sense of smell and taste in employees of retirement and nursing homes during SARS-CoV-2 pandemic.
    Jungbauer F; Huber L; Lammert A; Ludwig S; Rotter N; Zaubitzer L; Schell A
    Nurs Open; 2022 Jan; 9(1):175-180. PubMed ID: 34599864
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.
    Makaronidis J; Firman C; Magee CG; Mok J; Balogun N; Lechner M; Carnemolla A; Batterham RL
    BMC Infect Dis; 2021 Feb; 21(1):221. PubMed ID: 33632171
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Design and Evaluation of a Potential Non-Invasive Neurostimulation Strategy for Treating Persistent Anosmia in Post-COVID-19 Patients.
    Gracia DI; Ortiz M; Candela T; Iáñez E; Sánchez RM; Díaz C; Azorín JM
    Sensors (Basel); 2023 Jun; 23(13):. PubMed ID: 37447728
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Sudden loss of smell and taste: clinical predictors of coronavirus disease 2019 infection.
    Jain A; Kaur J; Kahlon N; Singh M; Rai AK; Hans M; Hans VM; Dhankar S; Kumar S; Pandey AK
    J Laryngol Otol; 2022 Aug; 136(8):747-749. PubMed ID: 35475481
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Residual olfactory dysfunction in coronavirus disease 2019 patients after long term recovery.
    Zhu Y; Cao M; Zheng P; Shen W
    J Clin Neurosci; 2021 Nov; 93():31-35. PubMed ID: 34656257
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Loss of smell in COVID-19 patients: a critical review with emphasis on the use of olfactory tests.
    Marchese-Ragona R; Restivo DA; De Corso E; Vianello A; Nicolai P; Ottaviano G
    Acta Otorhinolaryngol Ital; 2020 Aug; 40(4):241-247. PubMed ID: 33100334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.